Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Institutional

Prof. Catherine Lubetzki, winner of the Prize Pasteur-Weizmann / Servier 2021

Published on: 09/12/2021 Reading time: 1 min
Pr Catherine Lubetzki

Prof. Catherine Lubetzki, winner of the Prize Pasteur-Weizmann / Servier 2021 for her work on myelin regeneration in the treatment of multiple sclerosis

Awarded every three years, the Prize Pasteur-Weizmann / Servier rewards an internationally recognised researcher, doctor or scientist and/or his or her team for a major contribution to a biomedical discovery leading to a therapeutic application.

The Prize Pasteur-Weizmann / Servier dedicated this year to neurodegenerative pathologies has been awarded to Professor Catherine Lubetzki, Head of the Neuroscience Department of AP-HP Sorbonne University and Medical Director of the Brain Institute. It honours the career of a clinical researcher mainly dedicated to MS who has constantly combined basic research with her clinical activity of therapeutic management and support for many MS patients.

The Paris Brain Institut is delighted to receive this award, which recognises the work of Catherine Lubetzki and her team in developing experimental models, understanding the mechanisms involved and identifying therapeutic targets, leading to the initiation of therapeutic trials in patients with multiple sclerosis. In addition, the imaging work carried out under the supervision of Prof. Bruno Stankoff, who co-leads the research team, has made it possible to quantify demyelination and remyelination in humans and has thus highlighted inter-individual heterogeneity in myelin repair capacities.

The prize of 250,000 euros will be awarded to the research team "Remyelination in multiple sclerosis: from biology to clinical translation" co-directed by Professors Catherine Lubetzki and Bruno Stankoff at the Paris Brain Institute.

Our news on the subject

Les participants du Dîner annuel de Paris Brain Institute America
Annual Dinner of Paris Brain Institute America at the French Consulate in New York – A Resounding Success for Neuroscience Research
On October 8, 2024, the French Consulate in New York hosted the annual dinner of Paris Brain Institute America (PBIA), gathering prominent philanthropists and influential figures from the scientific community for an evening dedicated to transatlantic...
10.15.2024 Support
erc
Nikolas Karalis, team leader at the Paris Brain Institute, is awarded the ERC Starting Grant 2024.
The European Research Council's (ERC) Starting Grants are prestigious and highly competitive awards, designed to enable young scientists to build their research team, and to carry out ambitious and innovative projects addressing unexplored scientific...
09.16.2024 Institutional
L'une des présentation lors de la visite
A special international visit: members and friends of the International Olympic Committee discover Paris Brain Institute
On Wednesday July 31, the Institute had the pleasure of welcoming a special group of visitors: members of the International Olympic Committee (IOC) and their friends and families.
09.08.2024 Institutional
Des mains de chercheuse qui manipulent
New edition of the Big Brain Theory program for bold ideas (BBT4)
In 2024, Paris Brain Institute launched the 4th edition of the Big Brain Theory Program (BBT), designed to foster new and bold projects addressing the next challenges in neuroscience. For the first time, this call is open to our international...
06.14.2024 Institutional
image
A 7-Tesla MRI machine at Paris Brain Institute - behind the scenes of this incredible technology
It was a long-awaited event. On Sunday June 9, 2024, Paris Brain Institute welcomed an incredible piece of technology into its facilities: the latest generation MAGNETOM Terra X (Siemens Healthineers) 7T MRI. Teams have been doing a great deal of...
08.14.2024 Institutional
Neurone de la rétine prolongé par un long axone entouré de sa gaine de myéline. Crédit : Annie Cavanagh, Wellcome collection.
Early cortical remyelination has a neuroprotective effect in multiple sclerosis
Multiple sclerosis is a heterogeneous disease whose manifestations vary considerably from patient to patient and whose course appears, on the surface, unpredictable. Hence, it is crucial to identify the factors that drive disability progression. In a...
04.02.2024 Research, science & health
See all our news